Search Results 741-750 of 11372 for anti-TNF drugs

  1. Clinical trials - Oncology (Medical)

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...

  2. Emicizumab In Patients With Acquired Hemophilia A - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Anti-FVIII IgA-positive patients achieved partial remission similar to ...

  3. Study To Compare The Safety And Effectiveness Of Treatment Combinations In Patients With Recurrent Ovarian Cancer - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of the niraparib combinations defined in each cohort-specific supplement, as assessed by ...

  4. Lymphoma - Diagnosis and treatment - Mayo Clinic

    Treatment · Watch and wait · Chemotherapy · Immunotherapy · Radiation therapy · Targeted therapy · Clinical trials · CAR-T cell therapy · Bone marrow transplant.

  5. Breast cancer treatment Archives - Mayo Clinic News Network

    inhibitors, this treatment aims to prevent the deactivation and increase the body's anti-tumor immune response. At this time, immunotherapy is approved ...

  6. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine As First-Line Treatment For Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), Or Low-Blast Acute Myelogenous Leukemia (AML) - Mayo Clinic

    Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine As First-Line Treatment For Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), ...

  7. Clinical trials - Oncology (Medical)

    The objectives are to describe the practice patterns of therapeutic agents for treatment ... To verify the performance characteristics of anti ... A Study Of The ...

  8. Arthritis - Doctors and departments - Mayo Clinic

    Arthritis · Request an Appointment · Symptoms & causes · Diagnosis & treatment ...

  9. A Dose Escalation And Confirmation Study Of PT-112 In Advanced Solid Tumors In Combination With Avelumab - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... anti-PD-L1 antibody, avelumab, in selected advanced solid tumors. ... Concurrent cancer treatment with ...

  10. An Extension Study Of Oral Ozanimod For Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    treatment with Class Ia or Class III anti-arrhythmic drugs or treatment with 2 or more agents in combination known to prolong PR interval;; treatment with ...